|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/32 | |
| A61K 38/16 | |||
| A61K 38/22 | |||
| A61K 38/17 |
| (11) | Number of the document | 1984017 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07716710.4 |
| Date of filing the European patent application | 2007-01-17 | |
| (97) | Date of publication of the European application | 2008-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/001206 |
| Date | 2007-01-17 |
| (87) | Number | WO 2007/084544 |
| Date | 2007-07-26 |
| (30) | Number | Date | Country code |
| 759051 P | 2006-01-17 | US |
| (72) |
GOLDSTEIN, Allan, L., US
FINKELSTEIN, J.J., US
|
| (73) |
RegeneRx Biopharmaceuticals, Inc.,
15245 Shady Grove Road, Suite 470, Rockville, MD 20850,
US
|
| (54) | METHODS OF TREATING OR PREVENTING TISSUE DAMAGE CAUSED BY INCREASED BLOOD FLOW |
| METHODS OF TREATING OR PREVENTING TISSUE DAMAGE CAUSED BY INCREASED BLOOD FLOW |